$SKIN
Beauty Health Co

2021 Q4 Form 10-Q Financial Statement

#000181809321000113 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021 Q2
Revenue $77.89M $68.15M $66.51M
YoY Change 97.18% 371.15%
Cost Of Revenue $21.13M $22.07M $19.26M
YoY Change -59.29% 62.26% 95.7%
Gross Profit $56.76M $46.08M $47.25M
YoY Change -15.53% 119.85% 1005.03%
Gross Profit Margin 72.87% 67.61% 71.05%
Selling, General & Admin $58.77M $49.65M $70.62M
YoY Change -27.45% 182.19% 508.86%
% of Gross Profit 103.53% 107.76% 149.45%
Research & Development $1.875M $1.880M $2.988M
YoY Change -44.85% 225.82% 400.5%
% of Gross Profit 3.3% 4.08% 6.32%
Depreciation & Amortization $9.349M $1.028M $700.0K
YoY Change -35.08% 51.85% 16.67%
% of Gross Profit 16.47% 2.23% 1.48%
Operating Expenses $63.97M $51.53M $73.60M
YoY Change 5187.02% 183.57% 503.56%
Operating Profit -$7.212M -$5.456M -$26.35M
YoY Change -110.93% -295.91% 232.78%
Interest Expense -$2.894M -$530.0K -$2.060M
YoY Change -2994.0% -90.58% -63.65%
% of Operating Profit
Other Income/Expense, Net -$6.142M -$210.8M -$114.9M
YoY Change 3669.99% 1977.67%
Pretax Income -$16.25M -$216.3M -$141.2M
YoY Change 1363.78% 7604.81% 950.25%
Income Tax $1.063M -$1.100M -$1.900M
% Of Pretax Income
Net Earnings -$17.31M -$215.1M -$139.4M
YoY Change 1459.55% 9617.48% 1240.56%
Net Earnings / Revenue -22.23% -315.71% -209.57%
Basic Earnings Per Share -$1.63 -$1.52
Diluted Earnings Per Share -$117.9K -$1.63 -$1.52
COMMON SHARES
Basic Shares Outstanding 149.6M shares 132.3M shares 91.80M shares
Diluted Shares Outstanding 132.3M shares 91.80M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $901.9M $718.6M $101.5M
YoY Change 27229.88%
Cash & Equivalents $901.9M $718.6M $101.5M
Short-Term Investments
Other Short-Term Assets $12.32M $7.745M $4.804M
YoY Change 1953.67% 1836.25%
Inventory $35.26M $28.11M $23.76M
Prepaid Expenses $7.745M $4.804M
Receivables $46.82M $38.39M $40.13M
Other Receivables $4.599M $4.947M $4.279M
Total Short-Term Assets $1.001B $797.8M $174.4M
YoY Change 1593.7% 199351.25%
LONG-TERM ASSETS
Property, Plant & Equipment $31.18M $12.07M $10.11M
YoY Change 239.19%
Goodwill $123.7M $122.9M $103.1M
YoY Change 25.54% 24.72% 4.68%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.705M $4.758M $2.489M
YoY Change 39.31%
Total Long-Term Assets $217.9M $200.1M $168.1M
YoY Change 33.09%
TOTAL ASSETS
Total Short-Term Assets $1.001B $797.8M $174.4M
Total Long-Term Assets $217.9M $200.1M $168.1M
Total Assets $1.219B $997.9M $342.5M
YoY Change 446.95% 249368.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.05M $18.12M $17.33M
YoY Change 57.15%
Accrued Expenses $14.72M $7.896M $21.40M
YoY Change 498.94% 3848.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $76.44M $49.47M $39.49M
YoY Change 147.13% 12267.0%
LONG-TERM LIABILITIES
Long-Term Debt $729.9M $728.9M $0.00
YoY Change
Other Long-Term Liabilities $0.00 $1.755M $1.767M
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $1.755M $1.767M
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $76.44M $49.47M $39.49M
Total Long-Term Liabilities $0.00 $1.755M $1.767M
Total Liabilities $916.5M $1.140B $326.4M
YoY Change 262.55% 284882.5%
SHAREHOLDERS EQUITY
Retained Earnings -$418.7M -$401.4M -$186.3M
YoY Change 860.26%
Common Stock $16.00K $14.00K $13.00K
YoY Change 300.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $302.3M -$142.1M $16.07M
YoY Change
Total Liabilities & Shareholders Equity $1.219B $997.9M $342.5M
YoY Change 446.95% 249368.75%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021 Q2
OPERATING ACTIVITIES
Net Income -$17.31M -$215.1M -$139.4M
YoY Change 1459.55% 9617.48% 1240.56%
Depreciation, Depletion And Amortization $9.349M $1.028M $700.0K
YoY Change -35.08% 51.85% 16.67%
Cash From Operating Activities $3.279M $298.0K -$31.43M
YoY Change -400.83% -97.44% 170.15%
INVESTING ACTIVITIES
Capital Expenditures -$8.530M -$2.106M -$4.980M
YoY Change -323.3% 249.47%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$17.98M -$4.139M
YoY Change -100.0%
Cash From Investing Activities -$8.530M -$20.08M -$9.119M
YoY Change -98.15% 539.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 188.2M 637.8M 133.0M
YoY Change -59.47% -3210.04% 547.85%
NET CHANGE
Cash From Operating Activities 3.279M 298.0K -31.43M
Cash From Investing Activities -8.530M -20.08M -9.119M
Cash From Financing Activities 188.2M 637.8M 133.0M
Net Change In Cash 183.0M 618.0M 92.50M
YoY Change 5546.88% -7064.07% 1136.85%
FREE CASH FLOW
Cash From Operating Activities $3.279M $298.0K -$31.43M
Capital Expenditures -$8.530M -$2.106M -$4.980M
Free Cash Flow $11.81M $2.404M -$26.45M
YoY Change -340.51% 159.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001818093
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
149639553 shares
dei Entity File Number
EntityFileNumber
001-39565
dei Entity Registrant Name
EntityRegistrantName
The Beauty Health Company
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1908962
dei Entity Address Address Line1
EntityAddressAddressLine1
2165 Spring Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Long Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90806
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
603-4996
dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
SKIN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
718622000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9486000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2677000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2032000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38386000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18576000 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7745000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3220000 USD
CY2021Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4947000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4611000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
28105000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
23202000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
797805000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
59095000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12070000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9191000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
59349000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
50935000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
122865000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
98531000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1028000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
270000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4758000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4813000 USD
CY2021Q3 us-gaap Assets
Assets
997875000 USD
CY2020Q4 us-gaap Assets
Assets
222835000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
18118000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18485000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21274000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9475000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7896000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2458000 USD
CY2021Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2180000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2021Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
512000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
49468000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30930000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1755000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1854000 USD
CY2021Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0 USD
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
216024000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2676000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3987000 USD
CY2021Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
357173000 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
CY2021Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
728858000 USD
CY2020Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1139930000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
252795000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
133490012 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
133490012 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35501743 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35501743 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
14000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
260908000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13952000 USD
CY2021Q3 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
0 USD
CY2020Q4 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
554000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1576000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
242000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-401401000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43604000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-142055000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-29960000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
997875000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
222835000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68147000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34560000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
182197000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
81212000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
22072000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
13603000 USD
us-gaap Cost Of Revenue
CostOfRevenue
57131000 USD
us-gaap Cost Of Revenue
CostOfRevenue
37050000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
46075000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
20957000 USD
us-gaap Gross Profit
GrossProfit
125066000 USD
us-gaap Gross Profit
GrossProfit
44162000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30451000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10541000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
74530000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34425000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1880000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
577000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6320000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2549000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19200000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7054000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73643000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19659000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
51531000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
18172000 USD
us-gaap Operating Expenses
OperatingExpenses
154493000 USD
us-gaap Operating Expenses
OperatingExpenses
56633000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5456000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2785000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-29427000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-12471000 USD
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-530000 USD
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5629000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8289000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-15447000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4290000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
84000 USD
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
199306000 USD
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
271333000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q3 skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
10575000 USD
CY2020Q3 skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
0 USD
skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
47100000 USD
skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
0 USD
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-431000 USD
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
14000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-663000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-108000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-210818000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5592000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-331675000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15471000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-216274000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2807000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-361102000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27942000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1129000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-593000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3305000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6260000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-215145000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2214000 USD
us-gaap Net Income Loss
NetIncomeLoss
-357797000 USD
us-gaap Net Income Loss
NetIncomeLoss
-21682000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1537000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
108000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1818000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
20000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-216682000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2106000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-359615000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21662000 USD
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.63
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.63
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132306346 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132306346 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35392316 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35392316 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87219681 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87219681 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33870903 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33870903 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1208000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-9070000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-72000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-10324000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
224000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10397000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-16000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-20513000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2214000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
108000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-22543000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-29960000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3274000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-33205000 USD
CY2021Q2 skin Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
183864000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1557000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3508000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-139378000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-276000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
16070000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
7784000 USD
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
136575000 USD
CY2021Q3 skin Stock Issued During Period Value Reverse Recapitalization Working Capital Adjustment
StockIssuedDuringPeriodValueReverseRecapitalizationWorkingCapitalAdjustment
-734000 USD
CY2021Q3 skin Adjustments To Additional Paid In Capital Option Indexed To Issuers Equity
AdjustmentsToAdditionalPaidInCapitalOptionIndexedToIssuersEquity
90150000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5082000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-215145000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1537000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-142055000 USD
us-gaap Net Income Loss
NetIncomeLoss
-357797000 USD
us-gaap Net Income Loss
NetIncomeLoss
-21682000 USD
us-gaap Depreciation
Depreciation
2446000 USD
us-gaap Depreciation
Depreciation
1441000 USD
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
956000 USD
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
802000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
758000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1899000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8384000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8665000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
99000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
99000 USD
skin Write Off And Amortization Of Deferred Debt Issuance Costs
WriteOffAndAmortizationOfDeferredDebtIssuanceCosts
3005000 USD
skin Write Off And Amortization Of Deferred Debt Issuance Costs
WriteOffAndAmortizationOfDeferredDebtIssuanceCosts
1055000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8624000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
326000 USD
us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
0 USD
us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
36000 USD
skin Below Market Lease Write Down
BelowMarketLeaseWriteDown
0 USD
skin Below Market Lease Write Down
BelowMarketLeaseWriteDown
384000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
23000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
4130000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
3938000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5330000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-952000 USD
skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
47100000 USD
skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
271333000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-2014000 USD
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17290000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4055000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4503000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-230000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
336000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
5118000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2499000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1140000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2009000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
224000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8048000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1398000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
15624000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1823000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-100000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
913000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1799000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2668000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31640000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12025000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
22896000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
781000 USD
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2229000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
108000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4857000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2589000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29201000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2697000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
750000000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
90150000 USD
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
5000000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
6500000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
5000000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
15000000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
30000000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
21341000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
77000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
225486000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1329000 USD
skin Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
357802000 USD
skin Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
0 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
901000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
770825000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
709984000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19193000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4471000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-848000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9486000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7307000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
718622000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11848000 USD
us-gaap Interest Paid Net
InterestPaidNet
10249000 USD
us-gaap Interest Paid Net
InterestPaidNet
10432000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
188000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2399000 USD
us-gaap Stock Issued1
StockIssued1
136575000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Accounts Receivable Acquired1
NoncashOrPartNoncashAcquisitionAccountsReceivableAcquired1
6623000 USD
us-gaap Noncash Or Part Noncash Acquisition Accounts Receivable Acquired1
NoncashOrPartNoncashAcquisitionAccountsReceivableAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
2153000 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
90000 USD
CY2021Q3 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
4 business
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
512000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
739000 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 skin Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
653.109
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates and assumptions in preparing consolidated financial statements</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing its consolidated financial statements in conformity with GAAP, the Company makes assumptions, estimates, and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of net sales and expenses during the reported periods. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, allowance for doubtful accounts, the realizability of inventory, fair value measurements including </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock, warrant liabilities and earn-out shares liability </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuations, useful lives of property and equipment, goodwill and finite-lived intangible assets, accounting for income taxes, stock-based compensation expense and commitments and contingencies. The Company’s estimates are based on historical experience and on its future expectations that are believed to be reasonable. The combination of these factors forms the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from its current estimates and those differences may be material.</span></div>
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 skin Reverse Recapitalization Equity Interest Issued Or Issuable Number Of Shares
ReverseRecapitalizationEquityInterestIssuedOrIssuableNumberOfShares
7500000 shares
CY2021Q3 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
4 business
CY2021Q3 skin Stock Issued During Period Shares Reverse Recapitalization
StockIssuedDuringPeriodSharesReverseRecapitalization
7500000 shares
CY2021Q2 skin Common Stock Convertible Conversion Ratio
CommonStockConvertibleConversionRatio
1
CY2021Q2 skin Reverse Recapitalization Consideration Received
ReverseRecapitalizationConsiderationReceived
783000000 USD
CY2021Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
350000000 USD
CY2021Q2 skin Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
433000000 USD
CY2021Q2 skin Reverse Recapitalization Cash Paid To Shareholders
ReverseRecapitalizationCashPaidToShareholders
368000000 USD
CY2021Q2 skin Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
57000000 USD
CY2021Q2 skin Stock Converted Reverse Recapitalization
StockConvertedReverseRecapitalization
35501743 shares
CY2021Q3 skin Stock Issued During Period Value Reverse Recapitalization Working Capital Adjustment
StockIssuedDuringPeriodValueReverseRecapitalizationWorkingCapitalAdjustment
-700000 USD
CY2021Q3 skin Stock Issued During Period Shares Reverse Recapitalization Working Capital Adjustment
StockIssuedDuringPeriodSharesReverseRecapitalizationWorkingCapitalAdjustment
70860 shares
skin Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
433382000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
350000000 USD
skin Reverse Recapitalization Cash Paid To Shareholders
ReverseRecapitalizationCashPaidToShareholders
367870000 USD
skin Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
56976000 USD
skin Reverse Recapitalization Cash Paid For Working Capital Adjustments
ReverseRecapitalizationCashPaidForWorkingCapitalAdjustments
734000 USD
skin Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
357802000 USD
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
35000000 shares
CY2021Q2 skin Stock Issued During Period Shares Reverse Recapitalization
StockIssuedDuringPeriodSharesReverseRecapitalization
89827310 shares
CY2021Q2 skin Stock Converted Reverse Recapitalization
StockConvertedReverseRecapitalization
35501743 shares
CY2021Q2 skin Stock Issued During Period Shares Reverse Recapitalization Working Capital Adjustment
StockIssuedDuringPeriodSharesReverseRecapitalizationWorkingCapitalAdjustment
70860 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
125399913 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54358 shares
CY2021Q2 skin Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
653.109
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68147000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34560000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
182197000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
81212000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11693000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
9335000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
16412000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13867000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
28105000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
23202000 USD
CY2021Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
10561000 USD
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3535000 USD
CY2021Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1218000 USD
CY2020Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1388000 USD
CY2021Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1881000 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1132000 USD
CY2021Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7614000 USD
CY2020Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
3420000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21274000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9475000 USD
CY2021Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2867000 USD
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1538000 USD
CY2021Q3 skin Notes Payable Business Acquisition Current
NotesPayableBusinessAcquisitionCurrent
2154000 USD
CY2020Q4 skin Notes Payable Business Acquisition Current
NotesPayableBusinessAcquisitionCurrent
0 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2875000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
920000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7896000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2458000 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6689000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4407000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12070000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9191000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
1000000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
700000 USD
us-gaap Depreciation
Depreciation
2400000 USD
us-gaap Depreciation
Depreciation
1400000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
1028000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
677000 USD
us-gaap Depreciation
Depreciation
2446000 USD
us-gaap Depreciation
Depreciation
1441000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
111904000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
52555000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
59349000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
93978000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
43043000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
50935000 USD
CY2021Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
3500000 USD
CY2020Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
3100000 USD
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
9400000 USD
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
9500000 USD
CY2021Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
3503000 USD
CY2020Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
3068000 USD
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
9354000 USD
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
9467000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
98531000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
98520000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
25304000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-970000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-10000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
122865000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
98510000 USD
CY2021Q3 skin Debt Instrument Debt Default Default Interest Rate Maximum
DebtInstrumentDebtDefaultDefaultInterestRateMaximum
0.0100
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2300000 USD
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
2000000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
500000 USD
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
400000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1100000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1100000 USD
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3300000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6300000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0053
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0092
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.211
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.224
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
skin Effective Income Tax Rate Reconciliation Cares Act Amount
EffectiveIncomeTaxRateReconciliationCARESActAmount
-200000 USD
CY2020Q4 skin Income Tax Federal Refund Estimate Net Operating Loss Carryback Cares Act
IncomeTaxFederalRefundEstimateNetOperatingLossCarrybackCARESAct
4500000 USD
skin Cares Act Change In Interest Expense Limitations Income Tax Benefit
CARESActChangeInInterestExpenseLimitationsIncomeTaxBenefit
1200000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5100000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8600000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9399200 shares
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
326000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
1400000 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.90
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
149000 shares
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5082000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
76000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8624000 USD
CY2021Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
11500000 shares
CY2021Q2 skin Reverse Recapitalization Lock Up Agreement No Trade Period
ReverseRecapitalizationLockUpAgreementNoTradePeriod
P180D
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000 USD
CY2021Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
149000 USD
CY2020Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
90000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
396000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
193000 USD
CY2021Q3 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
395000 USD
CY2020Q4 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
250000 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
133490012 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
133490012 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35501743 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35501743 shares
CY2021Q3 skin Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
68147000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34560000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
182197000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
81212000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-215145000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2214000 USD
us-gaap Net Income Loss
NetIncomeLoss
-357797000 USD
us-gaap Net Income Loss
NetIncomeLoss
-21682000 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132306346 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132306346 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35392316 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35392316 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87219681 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87219681 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33870903 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33870903 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.63
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64

Files In Submission

Name View Source Status
0001818093-21-000113-index-headers.html Edgar Link pending
0001818093-21-000113-index.html Edgar Link pending
0001818093-21-000113.txt Edgar Link pending
0001818093-21-000113-xbrl.zip Edgar Link pending
ex311-2021q310q.htm Edgar Link pending
ex312-2021q310q.htm Edgar Link pending
ex321-2021q310q.htm Edgar Link pending
ex322-2021q310q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skin-20210930.htm Edgar Link pending
skin-20210930.xsd Edgar Link pending
skin-20210930_cal.xml Edgar Link unprocessable
skin-20210930_def.xml Edgar Link unprocessable
skin-20210930_htm.xml Edgar Link completed
skin-20210930_lab.xml Edgar Link unprocessable
skin-20210930_pre.xml Edgar Link unprocessable